WHO WE ARE

OUR MISSION

Our mission is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics). With a robust radiopharmaceutical production and distribution network, mature contract manufacturing services and high value theranostic intellectual property, we are delivering on the promise of radiopharmaceuticals.

OUR HISTORY

From the development of the first PET camera in 1973, Dr. Michael Phelps has proven his passion and dedication for the future of PET. His vision began in equipment, building a core PET company comprised of innovation and has led to pioneering PET imaging. In 2006, the creation of SOFIE launched the aspiration of having a multifaceted approach to expand the reach of PET products for patients with advanced imaging needs. This was further realized in 2017 with the addition of a radiopharmacy network with global distribution capabilities.

Today the SOFIE team is equally passionate in bringing the vision to life by increasing the adoption and application diversity of theranostics. This is done by providing a suite of meticulously tailored offerings that facilitate the use of and access to the technology. With our premier radiopharmacy network, mature contract manufacturing services and high value theranostic intellectual property, SOFIE is dedicated to improving patient health.

FROM START TO CLINIC

Are you passionate about healthcare and improving the lives of patients? Join our team to make a difference.